Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: A randomised crossover trial

Thorax

Volumn 71, Issue 8, 2016, Pages 759-761

  Fraser, John F ^a   Spooner, Amy J ^a   Dunster, Kimble R ^a,b   Anstey, Chris M ^a,c   Corley, Amanda ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c NAMBOUR GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE;

ARTICLE; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DYSPNEA; END EXPIRATORY LUNG VOLUME; GAS FLOW; HUMAN; INTERMETHOD COMPARISON; LONG TERM OXYGEN THERAPY; LUNG VOLUME; MALE; NASAL HIGH FLOW OXYGEN THERAPY; OXYGEN THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIDAL VOLUME; TRANSCUTANEOUS CARBON DIOXIDE MONITORING; TRANSCUTANEOUS OXYGEN MONITORING; COHORT ANALYSIS; COMPARATIVE STUDY; LONG TERM CARE; OXIMETRY; PEAK EXPIRATORY FLOW; POSITIVE END EXPIRATORY PRESSURE; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

CARBON DIOXIDE; COHORT STUDIES; CROSS-OVER STUDIES; HUMANS; LONG-TERM CARE; MALE; OXIMETRY; OXYGEN INHALATION THERAPY; PEAK EXPIRATORY FLOW RATE; POSITIVE-PRESSURE RESPIRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY RATE; TIDAL VOLUME;

EID: 84962892132     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-207962     Document Type: Article

References (10)

1. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011;6:199-208.
2. Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care 2013;58:1621-4.
3. Corley A, Caruana LR, Barnett AG, et al. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth 2011;107:998-1004.
4. Dysart K, Miller TL, Wolfson MR, et al. Research in high flow therapy: mechanisms of action. Respir Med 2009;103:1400-5.
5. Chatila W, Nugent T, Vance G, et al. The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest 2004;126:1108-15.
6. Okuda M, Kashio M, Tanaka N, et al. Nasal high-flow oxygen therapy system for improving sleep-related hypoventilation in chronic obstructive pulmonary disease: a case report. J Med Case Rep 2014;8:341.
7. Bräunlich J, Beyer D, Mai D, et al. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration 2013;85:319-25.
8. Stéphan F, Barrucand B, Petit P, et al. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery. A randomized clinical trial. JAMA 2015;313:2331-9.
9. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372:2185-96.
10. Rea H, McAuley S, Jayaram L, et al. The clinical utility of long-term humidification therapy in chronic airways disease. Respir Med 2010;104:525-33.